In one of the world’s most unequal countries, Novo Nordisk is taking a stand for health equity. Focused on education and access, the company is launching a campaign to address obesity and related diseases in South Africa. With nearly half the population affected, they’re working with the Health Ministry and NPOs to bridge the healthcare gap, starting with a game-changing rollout of insulin pens in public hospitals. Phemelo speaks to Director of Market Access and Public Affairs at Novo Dordisk, Thabeng Leping on this critical step forward. Kayafm